The description of PD-ALS clinical complex supports the hypothesis of there being common neuropathological pathways related to the frequent co-occurrence of αSyn and tau aggregation in such brains, suggesting the synergistic interaction of these (and other) proteins in determining the neurodegenerative process. This evidence concerns the gene MAPT and amyotrophic lateral sclerosis.